- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02457780
Stress Management Program for World Trade Center (WTC) Responders
Mind-Body Treatment for WTC Responders With Comorbid PTSD and Respiratory Illness
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mind-body interventions including relaxation training and other coping skills are effective for patients with both mental and physical health problems. A leading mind-body treatment is the Relaxation Response Resiliency Program (3RP) developed at Harvard. This treatment has been shown to reduce both mental and physical health symptoms.
The objective of this study is to adapt the 3RP to WTC responders and test its ability to reduce both PTSD and respiratory symptoms. This treatment will be compared to a Health Enhancement Program that addresses negative health behaviors. The investigators will randomly assign 175 patients with ongoing WTC-related PTSD and respiratory illness to the 3RP or Health Enhancement Program and will assess outcomes immediately after the treatment and at 3 and 6 month follow-ups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Stony Brook, New York, United States, 11794
- Stony Brook University, Putnam Hall
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PCL score equal to or greater than 35
- 2 or more lower respiratory symptoms
Exclusion Criteria:
- Regular elicitation of the relaxation response
- History of psychosis
- Current unmanaged bipolar disorder
- History of suicide attempt --OR-- current ideation with plan or intent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Relaxation Response Resiliency Program
The Relaxation Response Resiliency Program (3RP) is an 8-session (90min/session) group based intervention which includes a variety of skills and techniques designed to address chronic stress.
Techniques used include psychoeducation on healthy lifestyle behaviors, goal-setting, CBT skills, relaxation training and self-monitoring.
|
The 3RP is designed to decrease psychiatric and physical health symptoms and build resiliency by teaching skills to (1) elicit the relaxation response, (2) decrease stress reactivity and (3) increase social connectedness.
Eliciting the relaxation response involves sustained mental focus with an attitude of receptive awareness with strategies aimed at reducing muscle tension, breathing rate, heart rate, and blood pressure.
Decreasing stress reactivity involves increasing awareness of the stress response and learning skills to proactively address stress.
Increasing connectedness involves skills to promote positive growth, self-efficacy and social support.
Other skills and experiential exercises focus on increasing acceptance, optimism, empathy, and appreciation to promote resiliency.
Other Names:
|
Active Comparator: Health Enhancement Program
The Health Enhancement Program (HEP) is an 8-session (90min/session) group based intervention which includes psychoeducation and self-monitoring of health behaviors (e.g., sleep hygiene, nutrition, exercise, substance use etc).
|
The HEP is designed to address comorbid physical and mental health symptoms via psychoeducation, self-monitoring and goal setting techniques.
It is an 8 session manualized group intervention which addresses topics including sleep hygiene, nutrition, exercise, working with a healthcare team, and substance use.
The program uses a variety of in-session activities to engage participants in discussion related to self-care and wellness principles.
Relapse prevention and long-term goal setting are addressed.
The program is designed to be implemented by professionals with a background in mental health.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-report WTC-related PTSD Symptoms
Time Frame: Change from baseline in WTC-related PTSD symptoms at 6-months
|
Assessed via self-report (PTSD Checklist Specific Stressor; PCL-S)
|
Change from baseline in WTC-related PTSD symptoms at 6-months
|
Clinician Rated WTC-related PTSD Symptoms
Time Frame: Change from baseline in WTC-related PTSD symptoms at 6-months
|
Assessed via clinician interview (SCID for DSM-IV-TR).
|
Change from baseline in WTC-related PTSD symptoms at 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lower Respiratory Symptoms
Time Frame: Change from baseline in lower respiratory symptoms at 6-months
|
Assessed via self-report
|
Change from baseline in lower respiratory symptoms at 6-months
|
Pulmonary Functioning
Time Frame: Change from baseline in pulmonary functioning at 6-months
|
Assessed via spirometry
|
Change from baseline in pulmonary functioning at 6-months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Adam Gonzalez, PhD, Stony Brook University Department of Psychiatry
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1U01OH010524-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Active, not recruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on Relaxation Response Resiliency Program (3RP)
-
Dana-Farber Cancer InstituteCompletedMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Massachusetts General HospitalBenson-Henry Institute for Mind Body MedicineCompletedDepression | Quality of Life | Stress | Atrial Fibrillation | Anxiety | HostilityUnited States
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH)CompletedResilience, PsychologicalUnited States
-
Massachusetts General HospitalAmerican Cancer Society, Inc.Completed
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis | Neurofibromatosis 2 | Schwannomatosis | Neurofibromatosis IUnited States
-
Massachusetts General HospitalThe Rappaport Foundation; The Claflin Distinguished Scholar AwardsNot yet recruitingVon Hippel-Lindau Disease | Genetic DisorderUnited States
-
Massachusetts General HospitalUnknownStress | Burnout, ProfessionalUnited States
-
Massachusetts General HospitalCompletedStress | Paroxysmal Atrial FibrillationUnited States
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Bay Cove Human Services; VinfenEnrolling by invitationDepression | Stress | Burnout | Sleep | Anxiety | Coping Skills | Physical Inactivity | Healthy EatingUnited States
-
NYU Langone HealthCompletedPost Traumatic Stress Disorder (PTSD)United States